Billy Kawasaki’s Insights - Billy’s most-liked answers from 5i Research. There is no news that would change fundamentals. It is trading at 48x earnings, so it is expensive and the market is not liking high valuation names right now. Would not buy on the negative momentum. Wait for confirmation of an uptrend before considering. Unlock Premium - Try 5i Free
Billy Kawasaki’s Insights - Billy’s most-liked answers from 5i Research. The revenues were short of estimates but the additional IPO cost is not surprising. New pharmacies are contributing to 55% revenue gains. The stock remains above IPO prices. Unlock Premium - Try 5i Free
Neighbourly Pharmacy Inc is a Canadian stock, trading under the symbol NBLY-T on the Toronto Stock Exchange (NBLY-CT). It is usually referred to as TSX:NBLY or NBLY-T
In the last year, 1 stock analyst published opinions about NBLY-T. 1 analyst recommended to BUY the stock. 0 analysts recommended to SELL the stock. The latest stock analyst recommendation is . Read the latest stock experts' ratings for Neighbourly Pharmacy Inc.
Neighbourly Pharmacy Inc was recommended as a Top Pick by on . Read the latest stock experts ratings for Neighbourly Pharmacy Inc.
Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.
1 stock analyst on Stockchase covered Neighbourly Pharmacy Inc In the last year. It is a trending stock that is worth watching.
On 2023-05-29, Neighbourly Pharmacy Inc (NBLY-T) stock closed at a price of $19.71.